Uj klinikai entitás a perinatológiában: a magzati gyulladásos válaszreakció szindróma.

Translated title of the contribution: New clinical entity in perinatology: fetal inflammatory response syndrome

Gábor Erdei, Péter Tóth, B. Vásárhelyi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

In spite of the adequate therapy serious inflammatory complications affect the majority of preterm neonates. Recently, the role of fetal inflammatory response syndrome has been emerged as a possible mechanism. This new clinical entity is characterised by the generalised activation of fetal immune system which is often the result of chorioamnionitis. The level of inflammatory cytokines (interleukin-6) often elevates in fetuses affected by this syndrome. Elevated cytokine levels induce the infiltration of inflammatory cells into the amnion and activate matrix metalloproteases in the fetus. As a result, preterm birth occurs. The high levels of inflammatory cytokines in the fetus are associated with the development of bronchopulmonary dysplasia and periventricular leukomalacia in the newborn. Except the elevation of fetal interleukin-6 levels there is still no specific clinical or laboratory sign of the fetal inflammatory response syndrome. Further investigation is needed to understand the importance of this syndrome in the development of perinatal complications and to develop specific laboratory tests for the early recognition.

Original languageHungarian
Pages (from-to)1515-1519
Number of pages5
JournalOrvosi Hetilap
Volume144
Issue number31
Publication statusPublished - Aug 3 2003

Fingerprint

Perinatology
Fetus
Cytokines
Interleukin-6
Periventricular Leukomalacia
Chorioamnionitis
Bronchopulmonary Dysplasia
Amnion
Premature Birth
Metalloproteases
Immune System

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Uj klinikai entitás a perinatológiában : a magzati gyulladásos válaszreakció szindróma. / Erdei, Gábor; Tóth, Péter; Vásárhelyi, B.

In: Orvosi Hetilap, Vol. 144, No. 31, 03.08.2003, p. 1515-1519.

Research output: Contribution to journalArticle

@article{b4c0bf2bf72e48d598d81a9478c871cc,
title = "Uj klinikai entit{\'a}s a perinatol{\'o}gi{\'a}ban: a magzati gyullad{\'a}sos v{\'a}laszreakci{\'o} szindr{\'o}ma.",
abstract = "In spite of the adequate therapy serious inflammatory complications affect the majority of preterm neonates. Recently, the role of fetal inflammatory response syndrome has been emerged as a possible mechanism. This new clinical entity is characterised by the generalised activation of fetal immune system which is often the result of chorioamnionitis. The level of inflammatory cytokines (interleukin-6) often elevates in fetuses affected by this syndrome. Elevated cytokine levels induce the infiltration of inflammatory cells into the amnion and activate matrix metalloproteases in the fetus. As a result, preterm birth occurs. The high levels of inflammatory cytokines in the fetus are associated with the development of bronchopulmonary dysplasia and periventricular leukomalacia in the newborn. Except the elevation of fetal interleukin-6 levels there is still no specific clinical or laboratory sign of the fetal inflammatory response syndrome. Further investigation is needed to understand the importance of this syndrome in the development of perinatal complications and to develop specific laboratory tests for the early recognition.",
author = "G{\'a}bor Erdei and P{\'e}ter T{\'o}th and B. V{\'a}s{\'a}rhelyi",
year = "2003",
month = "8",
day = "3",
language = "Hungarian",
volume = "144",
pages = "1515--1519",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "31",

}

TY - JOUR

T1 - Uj klinikai entitás a perinatológiában

T2 - a magzati gyulladásos válaszreakció szindróma.

AU - Erdei, Gábor

AU - Tóth, Péter

AU - Vásárhelyi, B.

PY - 2003/8/3

Y1 - 2003/8/3

N2 - In spite of the adequate therapy serious inflammatory complications affect the majority of preterm neonates. Recently, the role of fetal inflammatory response syndrome has been emerged as a possible mechanism. This new clinical entity is characterised by the generalised activation of fetal immune system which is often the result of chorioamnionitis. The level of inflammatory cytokines (interleukin-6) often elevates in fetuses affected by this syndrome. Elevated cytokine levels induce the infiltration of inflammatory cells into the amnion and activate matrix metalloproteases in the fetus. As a result, preterm birth occurs. The high levels of inflammatory cytokines in the fetus are associated with the development of bronchopulmonary dysplasia and periventricular leukomalacia in the newborn. Except the elevation of fetal interleukin-6 levels there is still no specific clinical or laboratory sign of the fetal inflammatory response syndrome. Further investigation is needed to understand the importance of this syndrome in the development of perinatal complications and to develop specific laboratory tests for the early recognition.

AB - In spite of the adequate therapy serious inflammatory complications affect the majority of preterm neonates. Recently, the role of fetal inflammatory response syndrome has been emerged as a possible mechanism. This new clinical entity is characterised by the generalised activation of fetal immune system which is often the result of chorioamnionitis. The level of inflammatory cytokines (interleukin-6) often elevates in fetuses affected by this syndrome. Elevated cytokine levels induce the infiltration of inflammatory cells into the amnion and activate matrix metalloproteases in the fetus. As a result, preterm birth occurs. The high levels of inflammatory cytokines in the fetus are associated with the development of bronchopulmonary dysplasia and periventricular leukomalacia in the newborn. Except the elevation of fetal interleukin-6 levels there is still no specific clinical or laboratory sign of the fetal inflammatory response syndrome. Further investigation is needed to understand the importance of this syndrome in the development of perinatal complications and to develop specific laboratory tests for the early recognition.

UR - http://www.scopus.com/inward/record.url?scp=0142169982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142169982&partnerID=8YFLogxK

M3 - Article

C2 - 14502865

AN - SCOPUS:0142169982

VL - 144

SP - 1515

EP - 1519

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 31

ER -